{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:13:47Z","timestamp":1792059227515,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cger.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:30:57Z","timestamp":1567769457000},"page":"53-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Orthostatic Hypotension in Parkinson Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Jose-Alberto","family":"Palma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cger.2019.09.002_bib1","first-page":"E4949","article-title":"Propagation of prions causing synucleinopathies in cultured cells","volume":"11","author":"Woerman","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cger.2019.09.002_bib2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological alpha-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cger.2019.09.002_bib3","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cger.2019.09.002_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.cger.2019.09.002_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jnc.13595","article-title":"a-Synuclein strains and the variable pathologies of synucleinopathies","volume":"139","author":"Peelaerts","year":"2016","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cger.2019.09.002_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.WNL.0000148603.44618.19","article-title":"Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort","volume":"64","author":"Marras","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib7","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/brain\/awv151","article-title":"Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement","volume":"138","author":"Halliday","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.cger.2019.09.002_bib8","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.cger.2019.09.002_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"Natural history of pure autonomic failure: a United States prospective cohort","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Clinical practice. Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cger.2019.09.002_bib12","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.98.21.2290","article-title":"Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program","volume":"98","author":"Masaki","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cger.2019.09.002_bib13","first-page":"1752","article-title":"Nocturnal hypertension and dysautonomia in patients with Parkinson's disease: are they related?","volume":"260","author":"Berganzo","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","article-title":"Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?","volume":"30","author":"Palma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2019.09.002_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.cger.2019.09.002_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mdc3.12478","article-title":"Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension","volume":"4","author":"Palma","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.cger.2019.09.002_bib17","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/01.WNL.0000125192.69777.6D","article-title":"Autonomic dysfunction in dementia with Lewy bodies","volume":"62","author":"Thaisetthawatkul","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","article-title":"Autonomic dysfunction in Parkinson disease","volume":"117","author":"Kaufmann","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cger.2019.09.002_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cger.2019.09.002_bib21","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1177\/0271678X16667524","article-title":"Cerebral autoregulation and symptoms of orthostatic hypotension in familial dysautonomia","volume":"37","author":"Fuente Mora","year":"2017","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.cger.2019.09.002_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02292768","article-title":"Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure","volume":"11","author":"Horowitz","year":"2001","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mds.26516","article-title":"An orthostatic hypotension mimic: the inebriation-like syndrome in Parkinson disease","volume":"31","author":"Palma","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2019.09.002_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e328356c52f","article-title":"Management approaches to hypertension in autonomic failure","volume":"21","author":"Arnold","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cger.2019.09.002_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","article-title":"Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000002030","article-title":"Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study","volume":"85","author":"Gibbons","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10286-017-0414-x","article-title":"Clinical classification of orthostatic hypotensions","volume":"27","author":"Cheshire","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10286-014-0244-z","article-title":"Lack of orthostatic symptoms in dementia patients with orthostatic hypotension","volume":"25","author":"Bengtsson-Lindberg","year":"2015","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.25170","article-title":"Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies","volume":"83","author":"Norcliffe-Kaufmann","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10286-014-0229-y","article-title":"Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?","volume":"24","author":"Norcliffe-Kaufmann","year":"2014","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/CIRCULATIONAHA.105.598722","article-title":"Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study","volume":"114","author":"Rose","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cger.2019.09.002_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0895-7061(99)00257-5","article-title":"Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study","volume":"13","author":"Rose","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cger.2019.09.002_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ageing\/afp192","article-title":"The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study","volume":"39","author":"Kamaruzzaman","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.cger.2019.09.002_bib35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/pgmj.70.830.878","article-title":"Orthostatic hypotension and anti-hypertensive therapy in the elderly","volume":"70","author":"Fotherby","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cger.2019.09.002_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-121-3-199408010-00004","article-title":"The anemia of primary autonomic failure and its reversal with recombinant erythropoietin","volume":"121","author":"Biaggioni","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cger.2019.09.002_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01824009","article-title":"Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure","volume":"5","author":"Perera","year":"1995","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib38","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1152\/ajpregu.00544.2010","article-title":"The osmopressor response to water drinking","volume":"300","author":"May","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.cger.2019.09.002_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.parkreldis.2014.02.006","article-title":"Exercise hemodynamics in Parkinson's disease and autonomic dysfunction","volume":"20","author":"Low","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 3","key":"10.1016\/j.cger.2019.09.002_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1469-7793.1997.841ba.x","article-title":"Abnormal regional blood flow responses during and after exercise in human sympathetic denervation","volume":"505","author":"Puvi-Rajasingham","year":"1997","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cger.2019.09.002_bib41","first-page":"251","article-title":"Postural hypotension enhanced by exercise in patients with chronic autonomic failure","volume":"88","author":"Smith","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.cger.2019.09.002_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02556296","article-title":"Neurohumoral, peptidergic and biochemical responses to supine exercise in two groups with primary autonomic failure: Shy-Drager syndrome\/multiple system atrophy and pure autonomic failure","volume":"6","author":"Smith","year":"1996","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib43","series-title":"Human circulation: regulation during physical stress","author":"Rowell","year":"1986"},{"key":"10.1016\/j.cger.2019.09.002_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01819146","article-title":"Physical manoeuvres that reduce postural hypotension in autonomic failure","volume":"3","author":"Wieling","year":"1993","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib45","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00004872-198900076-00017","article-title":"Relationship between splanchnic vasodilation and postprandial hypotension in patients with primary autonomic failure","volume":"7","author":"Kooner","year":"1989","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.cger.2019.09.002_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-122-4-199502150-00009","article-title":"Postprandial hypotension: epidemiology, pathophysiology, and clinical management","volume":"122","author":"Jansen","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cger.2019.09.002_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10286-017-0440-8","article-title":"Postprandial hypotension in neurological disorders: systematic review and meta-analysis","volume":"27","author":"Pavelic","year":"2017","journal-title":"Clin Auton Res"},{"issue":"6","key":"10.1016\/j.cger.2019.09.002_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10286-017-0474-y","article-title":"Beat-to-beat blood pressure and heart rate responses to the Valsalva maneuver","volume":"27","author":"Goldstein","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib49","doi-asserted-by":"crossref","first-page":"H1768","DOI":"10.1152\/ajpheart.00287.2006","article-title":"Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study","volume":"291","author":"Krediet","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cger.2019.09.002_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10286-004-0188-9","article-title":"Segmental orthostatic fluid shifts","volume":"14","author":"Diedrich","year":"2004","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10286-004-0187-x","article-title":"Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction","volume":"14","author":"Smit","year":"2004","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/mdc3.12270","article-title":"Elastic abdominal binders attenuate orthostatic hypotension in Parkinson's disease","volume":"3","author":"Fanciulli","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.cger.2019.09.002_bib53","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/HYPERTENSIONAHA.116.07199","article-title":"Efficacy of Servo-controlled splanchnic venous compression in the treatment of orthostatic hypotension: a randomized comparison with midodrine","volume":"68","author":"Okamoto","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/jhh.2011.107","article-title":"Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome","volume":"27","author":"Norcliffe-Kaufmann","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.cger.2019.09.002_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM197907123010202","article-title":"Mineralocorticoid-induced hypertension in patients with orthostatic hypotension","volume":"301","author":"Chobanian","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cger.2019.09.002_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cger.2019.09.002_bib57","article-title":"Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension","volume":"6","author":"Grijalva","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cger.2019.09.002_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.cger.2019.09.002_bib59","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.cger.2019.09.002_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A\u00a0double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","article-title":"Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study","volume":"26","author":"Smith","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","article-title":"A\u00a0review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders","volume":"38","author":"McTavish","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.cger.2019.09.002_bib63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","article-title":"Droxidopa in neurogenic orthostatic hypotension","volume":"13","author":"Kaufmann","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cger.2019.09.002_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2004-817719","article-title":"Autonomic failure in neurodegenerative disorders","volume":"23","author":"Kaufmann","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","article-title":"The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale","volume":"22","author":"Kaufmann","year":"2012","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2019.09.002_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10286-016-0349-7","article-title":"Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension","volume":"26","author":"Elgebaly","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib69","first-page":"1","article-title":"Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?","volume":"27","author":"Kaufmann","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-017-0430-x","article-title":"Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension","volume":"27","author":"Gupta","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10286-017-0435-5","article-title":"Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus","volume":"27","author":"Vernino","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10286-017-0434-6","article-title":"Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease","volume":"27","author":"Kremens","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-017-0433-7","article-title":"Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension","volume":"27","author":"Mehdirad","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10286-017-0429-3","article-title":"Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease","volume":"27","author":"Claassen","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10286-017-0431-9","article-title":"Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease","volume":"27","author":"Goodman","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10286-017-0432-8","article-title":"Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy","volume":"27","author":"Goodman","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10286-017-0428-4","article-title":"Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease","volume":"27","author":"Gupta","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jash.2016.07.009","article-title":"Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension","volume":"10","author":"Kaufmann","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.cger.2019.09.002_bib79","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cger.2019.09.002_bib80","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2019.09.002_bib81","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.111.184812","article-title":"Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure","volume":"59","author":"Okamoto","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","article-title":"Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib83","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","article-title":"Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure","volume":"64","author":"Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib84","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.P5.320","article-title":"Norepinephrine levels predict the improvement in orthostatic symptoms after atomoxetine in patients with neurogenic orthostatic hypotension (P5.320)","volume":"88","author":"Shibao","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib85","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1212\/WNL.0000000000006369","article-title":"Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension","volume":"91","author":"Palma","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2019.09.002_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","article-title":"Multiple system atrophy: using clinical pharmacology to reveal pathophysiology","volume":"25","author":"Jordan","year":"2015","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cger.2019.09.002_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.118.11790","article-title":"Synergistic pressor effect of atomoxetine and pyridostigmine in patients with neurogenic orthostatic hypotension","volume":"73","author":"Okamoto","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.cger.2019.09.002_bib89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib90","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1001\/jama.1940.02810510038010","article-title":"Orthostatic hypotension and orthostatic tachycardia - treatment with the \"head-up\" bed","volume":"115","author":"MacLean","year":"1940","journal-title":"JAMA"},{"key":"10.1016\/j.cger.2019.09.002_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10286-017-0437-3","article-title":"Neurogenic orthostatic hypotension: the very basics","volume":"27","author":"Kaufmann","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cger.2019.09.002_bib92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10286-017-0479-6","article-title":"Treatment of supine hypertension in autonomic failure: a case series","volume":"28","author":"Di Stefano","year":"2018","journal-title":"Clin Auton Res"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069019300771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069019300771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:55:00Z","timestamp":1760061300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069019300771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0749069019300771"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2019.09.002","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orthostatic Hypotension in Parkinson Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}